目次

1. Introduction to Galectin Inhibitors
1.1 Overview
1.2 Discovery of Galectins and Their Inhibitors

2. Role of Galectin Inhibitors and Mechanism of Action by Indication
2.1 Cancer
2.2 Viral Infection
2.3 Liver Diseases
2.4 Neurodegenerative Disease
2.5 Cardiovascular Diseases

3. Global Galectin Inhibitors Clinical Trials Landscape
3.1 By Company
3.2 By Country
3.3 By Indication
3.4 By Phase
3.5 By Patient Segment

4. Global Galectin Inhibitors Clinical Pipeline By Company, Indication and Phase
4.1 Research
4.2 Preclinical
4.3 Phase-I/II
4.4 Phase-II
4.5 Phase-II/III

5. Global Galectin Inhibitors Market Dynamics
5.1 Favorable Factors and Opportunities
5.2 Challenges and Restraints

6. Global Galectin Inhibitors Market Opportunity Outlook

7. Competitive Landscape
7.1 BioXyTran
7.2 G3 Pharmaceuticals
7.3 Galectin Therapeutics
7.4 Galecto
7.5 GlycoMimetics
7.6 HiFiBiO
7.7 PureTech Health
7.8 TrueBinding
7.9 University Medical Center Groningen
7.10 University Of Michigan Medical School

List of Figures & Tables
Figure 1-1: Timeline of Discovery of Galectin Inhibitors
Figure 2-1: Roles of Galectins in Cancer
Figure 2-2: LYT-200 Phase I/II Study - Initiation and Completion Years
Figure 2-3: GR-MD-02 Phase I Study - Initiation and Completion Years
Figure 2-4: GB1211 Phase I/II Study - Initiation and Completion Years
Figure 2-5: Roles of Galectins in Viral Infections
Figure 2-6: ProLectin M Phase III PROTECT Study - Initiation and Completion Years
Figure 2-7: ProLectin-M Phase II Study - Initiation and Completion Years
Figure 2-8: Roles of Galectins in Liver Diseases
Figure 2-9: Belapectin Phase II/III NAVIGATE Study - Initiation and Completion Years
Figure 2-10: GB1211 Phase I/II GULLIVER-2 Study - Initiation and Completion Years
Figure 2-11: Roles of Galectins in Neurodegenerative Disease
Figure 2-12: Roles of Galectins in Cardiovascular Diseases
Figure 3-1: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Company (Numbers), 2023
Figure 3-2: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Country (Numbers), 2023
Figure 3-3: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Indication (Numbers), 2023
Figure 3-4: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Phase (Numbers), 2023
Figure 3-5: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Patient Segment (Numbers), 2023
Figure 5-1: Factors Driving Galectin Inhibitors Market
Figure 5-2: Factors Limiting Galectin Inhibitors Market
Table 2-1: Galectins and Their Disease Implications